Target intelligence / Profile preview

Tripartite motif-containing protein 24 (TRIM24)

Target
TRIM24
Molecular classification
E3 ubiquitin-protein ligase, Chromatin regulator, Transcription factor coactivator, Histone modification reader, Other (Tripartite motif family protein)
01

Overview

Tripartite motif-containing protein 24 (TRIM24) is a multi-domain nuclear protein belonging to the tripartite motif (TRIM) family, characterized by a RING/B-box/coiled-coil architecture, and also containing a plant homeodomain (PHD) and bromodomain that act as a combinatorial reader of specific histone modifications[1][3][4][5][6]. TRIM24 acts primarily as a chromatin-associated transcriptional coactivator, interacting with the activation function domains of several nuclear hormone receptors, including estrogen receptor (ER), androgen receptor (AR), retinoic acid, and vitamin D3 receptors[1][3][4][5]. It recruits and stabilizes transcription factors at their chromatin binding sites and modulates gene expression patterns linked to proliferation, cancer progression, and endocrine signaling[5][7]. Additionally, TRIM24 possesses E3 ubiquitin ligase activity, targeting proteins such as p53 and various innate immune pathway components for proteasomal degradation[4][6]. TRIM24 is dysregulated in multiple cancers, often acting as an oncogenic coactivator for STAT3 and nuclear receptors, and its overexpression correlates with poor prognosis, therapeutic resistance, and tumor aggressiveness[5][7]. Moreover, TRIM24 plays roles in cardiac gene expression, immune signaling, and chromatin remodeling, making it an emerging target for novel cancer therapies and a potential biomarker in oncology[2][5][7].

Other names
Transcription intermediary factor 1-alphaTIF1-alphaTIF1ARNF82E3 ubiquitin-protein ligase TRIM24RING finger protein 82RING-type E3 ubiquitin transferase TIF1-alphahTIF1PTC6TF1A
02

Mechanism of action

Proteasomal degradation of TRIM24 (by targeted protein degraders/PROTACs); Inhibition of TRIM24's coactivator functions (disrupting nuclear receptor or STAT3 interaction)

03

Biological functions

Transcriptional regulationChromatin remodelingProtein ubiquitinationCell proliferationCell death/apoptosisRegulation of nuclear receptor signalingInnate immune responseCalcium homeostasis
04

Disease associations

Cancer (oncogene in multiple cancers, including breast, glioma, HCC, NSCLC, gastric, and bladder)Endocrine resistance in breast cancerCardiovascular disease (cardiac hypertrophy, heart failure)Other (inflammation, pyroptosis in innate immunity, possibly metabolic regulation)
05

Safety considerations

Potential for broad effects on transcription, chromatin, and cell proliferationOn-target toxicity due to role in normal chromatin regulation, hormone signaling, and cell viabilityLimited targetability due to protein–protein and epigenetic "reader" activities
06

Interacting drugs

PROTAC-based TRIM24 degrader compounds (preclinical)

1 more in the full profile.

07

Biomarkers

TRIM24 overexpression as a prognostic biomarker in multiple cancers (glioma, breast, HCC, NSCLC, others)Co-expression with EGFR/p-STAT3 in glioblastoma as a signature of poor prognosisTRIM24 expression in endocrine-resistant breast cancer

Beyond the preview

Go deeper on Tripartite motif-containing protein 24 (TRIM24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif-containing protein 24 (TRIM24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call